Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03956927
Other study ID # PENNECOT 2019
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 24, 2019
Est. completion date July 11, 2019

Study information

Verified date May 2020
Source Centre Hospitalier Universitaire Dijon
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The benefits of Therapeutic Patient Education (TPE) have long been proven, but its implementation remains insufficient. It is only accessible to a part of the population and is too often limited to the acquisition of knowledge. TPE consists of supporting the patient in making decisions about his or her health, managing his or her life with the disease and treatment through the acquisition or maintenance of skills.

Simulation is a pedagogical method of creating fictional or reconstructed environments in order to develop skills, know-how and abilities for which direct instruction is impossible for ethical, economic or technical reasons. To date, it is recommended for the development of caregiver skills, and has been the subject of two studies among family caregivers. It seems likely that simulation will add value to the methods currently used in TPE.

To our knowledge, no studies have been conducted on simulation-based TPE (S-TPE) with patients.

A consensus conference, which is a rigorous method of comparing the opinions of experts in TPE, simulation, patient experts and caregivers, was held in order to determine the learning that could be developed through simulation and the conditions of use. However, since the patient is a specific type of learner, we hypothesize that there may be some additional conditions for the use of S-TPE. And the value of this approach remains to be demonstrated. Since the use of S-TPE has never been studied with patients, a feasibility test would make it possible to evaluate, in the context of care, the possibility of its use and its acceptance by both patients and caregivers. This is necessary before considering a multicenter trial that demonstrates an interest in developing patient skills. It was decided to carry out this study in patients with diabetes, a condition for which TPE is a precursor. Caregivers will be able to objectify the advantages and limitations of using S-TPE.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date July 11, 2019
Est. primary completion date July 11, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult who has provided non-opposition to participate in the study

- Insulin-dependent diabetic patient who has participated in a complete TPE program (3 sessions) for the implementation of a FreeStyle LibreĀ®.

Exclusion Criteria:

- Person subject to a legal protection measure (curatorship, guardianship)

- Person subject to limited judicial protection

- Pregnant, parturient or breastfeeding woman

- Adulat patients unable to provide consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
S-TPE
S-TPE stimulation session with groups of 8 patients. The simulation is performed by a single patient, the others are observers in a neighbouring room where the scene is projected.
Questionnaires
Pre- and post-simulation administration of self-efficacy and anxiety questionnaires (IASTA Y1 and Y2)

Locations

Country Name City State
France Chu Dijon Bourgogne Dijon

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary level of perceived utility of the S-TPE The level of perceived utility of S-TPE for patients and caregivers through self-administered Likert scale questionnaires Through study completion, an average of 9 months
Primary Patient satisfaction: Likert scale The degree of patient satisfaction at the end of the simulation sequence by self-administered questionnaire with a Likert scale Through study completion, an average of 9 months
Primary Organizational advantages and limitations Organizational, human, material, material and temporal facilities and limitations for patients and caregivers by analyzing the verbatim of the T0 questionnaires and interviewing them at T1 Through study completion, an average of 9 months
See also
  Status Clinical Trial Phase
Completed NCT01548729 - Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis Phase 1/Phase 2
Terminated NCT03411460 - Satisfaction of Hospitalized Diabetic Patients Using a Continuous Glucose Monitoring System N/A